Subependymal giant cell astrocytoma diagnostic criteria: Difference between revisions
Created page with "__NOTOC__ {{Subependymal giant cell astrocytoma}} {{CMG}}{{AE}}{{SR}} ==Overview== ==Diagnostic Criteria== ==Reference== {{reflist|2}} Category:Disease Category:Type..." |
Mahshid |
||
| (5 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The diagnosis of subependymal giant cell astrocytoma is based on the International Tuberous Sclerosis Complex Consensus criteria, which include a lesion at the caudothalamic groove with either a size of more than 1 cm in any direction or a subependymal lesion at any location that has shown serial growth on consecutive imaging regardless of size. Most subependymal giant cell astrocytomas will show avid enhancement after contrast administration; however, a growing subependymal lesion even in the absence of enhancement should be considered a subependymal giant cell astrocytoma. | |||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
The diagnosis of subependymal giant cell astrocytoma is based on the International Tuberous Sclerosis Complex Consensus criteria, which include:<ref name="RothRoach2013">{{cite journal|last1=Roth|first1=Jonathan|last2=Roach|first2=E. Steve|last3=Bartels|first3=Ute|last4=Jóźwiak|first4=Sergiusz|last5=Koenig|first5=Mary Kay|last6=Weiner|first6=Howard L.|last7=Franz|first7=David N.|last8=Wang|first8=Henry Z.|title=Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012|journal=Pediatric Neurology|volume=49|issue=6|year=2013|pages=439–444|issn=08878994|doi=10.1016/j.pediatrneurol.2013.08.017}}</ref> | |||
*A lesion at the caudothalamic groove with either a size of more than 1 cm in any direction or a subependymal lesion at any location that has shown serial growth on consecutive imaging regardless of size. Most subependymal giant cell astrocytomas will show avid enhancement after contrast administration; however, a growing subependymal lesion even in the absence of enhancement should be considered a subependymal giant cell astrocytoma. | |||
== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 17: | Line 20: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 17:00, 27 November 2017
|
Subependymal giant cell astrocytoma Microchapters |
|
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Subependymal giant cell astrocytoma diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma diagnostic criteria |
|
FDA on Subependymal giant cell astrocytoma diagnostic criteria |
|
CDC on Subependymal giant cell astrocytoma diagnostic criteria |
|
Subependymal giant cell astrocytoma diagnostic criteria in the news |
|
Blogs on Subependymal giant cell astrocytoma diagnostic criteria |
|
Risk calculators and risk factors for Subependymal giant cell astrocytoma diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
The diagnosis of subependymal giant cell astrocytoma is based on the International Tuberous Sclerosis Complex Consensus criteria, which include a lesion at the caudothalamic groove with either a size of more than 1 cm in any direction or a subependymal lesion at any location that has shown serial growth on consecutive imaging regardless of size. Most subependymal giant cell astrocytomas will show avid enhancement after contrast administration; however, a growing subependymal lesion even in the absence of enhancement should be considered a subependymal giant cell astrocytoma.
Diagnostic Criteria
The diagnosis of subependymal giant cell astrocytoma is based on the International Tuberous Sclerosis Complex Consensus criteria, which include:[1]
- A lesion at the caudothalamic groove with either a size of more than 1 cm in any direction or a subependymal lesion at any location that has shown serial growth on consecutive imaging regardless of size. Most subependymal giant cell astrocytomas will show avid enhancement after contrast administration; however, a growing subependymal lesion even in the absence of enhancement should be considered a subependymal giant cell astrocytoma.
References
- ↑ Roth, Jonathan; Roach, E. Steve; Bartels, Ute; Jóźwiak, Sergiusz; Koenig, Mary Kay; Weiner, Howard L.; Franz, David N.; Wang, Henry Z. (2013). "Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012". Pediatric Neurology. 49 (6): 439–444. doi:10.1016/j.pediatrneurol.2013.08.017. ISSN 0887-8994.